Ask AI

Aligning the Patient–Provider Therapeutic Connection to Improve Clinical Outcomes in Progressive HR+/HER2- Metastatic Breast Cancer

Gain expert insights into the management of progressive HR+/HER2- MBC, including toxicity mitigation and medication adherence, to optimize patient outcomes through certified interactive case challenges and downloadable slides.

Share

Program Content

Activities

HR Pos HER2 Neg mBC Oral SERDS
Aligning the Patient–Provider Therapeutic Connection to Improve Clinical Outcomes in Progressive HR+/HER2- Metastatic Breast Cancer
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 26, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC. in partnership with Smart Patients

Supporters

Supported by educational grants from AstraZeneca, Lilly, and Stemline Therapeutics, Inc.

AstraZeneca

Lilly

Stemline Therapeutics, Inc.

Partners

Smart Patients

ProCE Banner